20 percent relative reduction in TB cases reported to the CDC National Tuberculosis Surveillance System compared with 2019
WEDNESDAY, March 31, 2021 (HealthDay News) — In 2020, there was a large decrease in tuberculosis (TB) cases, according to research published in the March 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Molly Deutsch-Feldman, Ph.D., from the CDC in Atlanta, and colleagues describe the incidence of TB cases in the United States in 2020.
The researchers found that 7,163 TB cases were provisionally reported to the CDC National Tuberculosis Surveillance System by the 50 U.S. states and District of Columbia (DC), representing a 20 percent relative reduction compared with 2019. The incidence of TB per 100,000 persons was 2.2 compared with 2.7 during 2020 and 2019, respectively. Overall, 39 states and DC, eight states, and three states reported a decrease in cases, an increase in cases, and no change, respectively. The highest number of cases was reported in California (1,703 cases), while the highest incidence was seen in Alaska (7.9 cases per 100,000 persons). Pandemic mitigation efforts and reduced travel could have contributed to this decline, although the magnitude and breadth of the decrease suggests potentially missed or delayed diagnoses.
“Further work is in progress to examine the causes of the steep decrease in reported TB cases,” the authors write. “Identifying reversible causes of underdiagnosis or actual causes of an actual reduction in TB cases during 2020 will help identify effective public health responses.”
High-Dose Rifampin Not Beneficial for Tuberculosis Meningitis
Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
COVID-19 Pandemic Yielded Indirect Increases in Disease Burden
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Adverse Event Risk Not Up With Same Day COVID-19, Flu Vaccination